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Abstract
Gold Nanoparticles (AuNPs) have already a remarkable interest as viable biomedical materials. Additionally, the 
strategy of using biomolecules to modify their surface properties is a very attractive as it leads to the generation of new 
nanometric hybrid materials. In this respect, aptamers, functional small single-strand oligonucleotides (DNA or RNA), 
are ideal candidates for molecular targeting applications since the high affinity to their target molecules. Thus, the urge 
of new and effective methodologies to graft aptamers on AuNPs is rapidly increasing especially for applications in 
bioanalysis and biomedicine, including early diagnosis and drug delivery. Here we used two chemical methodologies to 
conjugate the aptamer (APT) onto pegylated gold nanoparticles (PEG-AuNPs): the carbodiimide chemistry (EDC/NHS) 
(methodology ON) and the chelation-bond (R-Au bond) (methodology IN). The aptamer's conjugations with the PEG-
AuNPs were characterized by UV-Vis absorption, Raman Spectroscopy and transmission electron microscopy (TEM). 
In addition, the potential nanotoxicity of the two aptamer-conjugated AuNPs was evaluated on two different renal cell 
lines, being the kidneys one of the most important site of bioaccumulation upon systemic circulation. Interestingly, the 
two aptamer-conjugated AuNPs showed different cytotoxicity when exposed to human embryonic kidney (HEK293) and 
mouse collecting duct cells (M-1), indicating that cell viability has to be taken into account when choosing the proper 
strategy for NPs production. In conclusion this study provides two effective methods to graft aptamers on NPs and 
important insights regarding NPs conformation and the relative cell viability.
Keywords: Colloids; Functionalization; Biological interaction; 
Biomarker; PEG-AuNPs; Raman Spectroscopy; Aptamer; SERS
Introduction 
During the last years, the nanoparticles were intensively used 
in industrial and medical applications [1-3]. Among them, Gold 
Nanoparticles (AuNPs) have a remarkable interest as viable biomedical 
materials and the research efforts about this subject are continuously 
growing due to their unique physical and chemical properties [4]. By 
using some of the biomolecules to modify the surface properties is a 
very attractive strategy, as it leads to a new generation of nanometric 
hybrid materials [5-7]. Several characteristics of such nanostructures 
have been identified as providing a better biocompatibility and furtivity 
to the nanoparticles or a better targeting of some specific disease 
biomarkers for nanosensor development or of some bio-structures as 
tumours or organs that have to be detected or treated [8]. Additionally, 
the physicochemical characteristics of NPs deeply impact their ability 
to migrate away from the organism’s entry site [9]. Liver, spleen and 
kidney possess a fenestrated endothelium that allows for passive 
accumulation of NPs and are potential sites for NPs off-target toxicity 
or target of the therapy [10]. In particular, biodistribution studies in 
vivo confirmed renal distribution of NPs [11-14] and this highlight 
the need of evaluating nanotoxicity at renal level. One of the most 
promising bioreceptors is the DNA aptamer, a DNA single strand 
(ssDNA) specially designed to have a high affinity to proteins [15] or 
other kinds of analytes as toxins [16,17]. Based on their high binding 
affinity and specificity towards other molecules, aptamers, can be 
utilized in applications ranging from biosensing to diagnostics and 
therapeutics [18-20]. Meanwhile, advances in nanotechnology have 
led to new and improved materials for biomedical applications [21]. 
Specifically, nanoparticles can readily interact with both intra- and 
extra-cellular biomolecules to yield improved signal amplification and 
target recognition [22]. To accomplish this, several parameters were 
investigated, including nanoparticle size, conjugation chemistry, use of 
multiple aptamer sequences on the nanoparticles, and use of multiple 
nanoparticles with different aptamer sequences [16,18]. In this context 
the study of the interaction between the bioreceptor (e.g. aptamer) 
and proteins is essential to improve the biomedical application of 
nanoparticles [23,24]. Among various analytes of interest, aquaporins 
(AQPs) are membrane water/glycerol channels that plays a key role in 
many physiological functions [25], as well as chemical tools to assess 
AQPs function in biological systems [25,26]. In recent years several 
gold (III) compounds have shown promising anticancer effects related 
to the inhibition of different protein targets, such as the proteasome and 
specific zinc finger proteins [27,28]. 
In particular, Soveral G et al. have described the selective and 
potent inhibitory effect (in the nanomolar range) of Au(III) complexes 
bearing nitrogen donor ligands on AQPs proteins, which together with 
their limited toxicity and high water solubility makes them suitable 
candidates for future in vivo studies [27]. The aim of the current paper, 
is to preliminary inquire the possibility to exploit the bioconjugation 
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of aptamer AQP-2 onto gold nanoparticle surface as two different 
chemical strategies in order to evaluate their biological interactions with 
kidney cells as well as the chemical physical characterization of AQP2 
aptamer onto gold nanoparticles. In particular, two methods for the 
aptamer grafting onto pegylated gold nanoparticles (PEG-AuNPs) was 
established: the carbodiimide chemistry [29] (reaction between COOH 
and NH2 chemical groups) and, for the first time, the chelation reaction 
concerning the complexation between Au-Cl and aptamer functional 
groups (PO43-; CO and/or NH2). 
Both aptamer-conjugated PEG-AuNPs underwent physicochemical 
characterization and tested for cytotoxicity on two different renal cell 
lines, human embryonic kidney (HEK293) and mouse collecting duct 
cells (M-1), respectively.
This study open the way to develop original protocols will be 
employed for decoration of hybrid nanoparticles in order to create 
aptamer-based nanomaterials, with high affinity cancer biomarkers. 
Materials and Methods
Tetrachloroauric acid (HAuCl4), sodium borohydride 
(NaBH4), dicarboxylic PolyEthylene Glycol (PEG)-600 (PEG), 
N-hydroxysuccinimide (NHS), 1-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC) and phosphate-buffered 
solution (PBS) were all provided by Sigma Aldrich at maximum purity 
grade. Aquaporin 2 aptamer was purchased from Eurogentec.
Aquaporin 2 aptamer(APT)
Aquaporin 2 Homo sapiens aptamer was purchased from 
Eurogentec. The aptamer was dispersed in PBS buffer (pH = 9). 
Cell culture and in vitro cytotoxicity assay
Human embryonic kidney cells HEK293 cells were cultured in 
DMEM Glutamax supplemented with 10% fetal bovine serum and 100 
i.u./ml penicillin, 100 μg/ml streptomycin at 5% CO2 and 37°C. Mouse 
cortical collecting duct M-1 cells [30] were maintained in DMEM/F12 
(1:1) supplemented with 5% fetal bovine serum, 2 mM L-glutamine, 100 
i.u./ml penicillin, 100 μg/ml streptomycin, and 5 μM dexamethasone. 
Cells were either left under basal condition or exposed to PEG-AuNPs 
(1 µM), APT ON PEG-AuNPs (1 µM) and APT IN PEG-AuNPs (1µM) 
for 6, 12, 24, 48 and 72 hours at 37°C to evaluate cytotoxicity using 
trypan blue exclusion assay. Briefly, an aliquot of the cell suspension was 
diluted 1:1 (v/v) with 0.4% trypan blue and viable cells were counted with 
a hemocytometer Luna II automated cell counter (Logos Biosystem). 
The percentage viability was calculated by dividing the number of viable 
cells by the number of all counted cells. Three independent experiments 
were carried out. Cell viability data were analyzed using Prism software 
(version 6.0; www.graphpad.com). Statistical differences between 
experimental conditions were determined by One-way Anova with 
Tukey’s multiple comparisons post-test. Data were expressed as means 
± SEM and p<0.05 was considered statistically significant.
Synthesis of PEG-AuNPs
Colloids of COOH-terminated PEG-coated AuNPs (PEG-AuNPs) 
were prepared by a well assessed chemical reduction process according 
to previously described procedure (Scheme 1) [2]. 
Determination of PEG-AuNPs concentration
AuNPs concentration was determined by exploiting standard 
mathematical calculations in colloidal solution as described previously [31]. 
Bioconjugation of PEG-AuNPs with aptamers
PEG-AuNPs surface was modified by APT aptamer, according to 
the grafting procedures depicted in Scheme 1.
Aptamer graftings onto peg-aunps by carbodiimide cross-
linker chemistry (apt on peg-aunps)
The first grafting strategy consists of the conjugation of the AQP2 
aptamer (APT) or on the PEG-AuNPs surface by carbodiimide 
Scheme 1: Schematic representation of the synthesis of a)APT ON PEG-AuNPs and b) APT IN PEG-AuNPs via 
carbodiimide chemistry (a) and chelation reaction (b) (Please note that drawings are not in scale and are not intended 
to be representative of the full samples composition). 
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on a carbon coated copper grid (Smethurst High-Light Ltd) and dried 
at room temperature.
Raman spectroscopy: The Raman experiments have been performed 
on an Xplora spectrometer (Horiba Scientifics-France). The Raman 
spectras have been recorded using an excitation wavelength of 785 nm 
(diode laser) at room temperature. For measurements in solution, a 
macro-objective with a focal length of 40 mm (NA = 0.18) was used in 
backscattering configuration. The achieved spectral resolution is close 
to 2 cm-1.
Dynamic light scattering (DLS) and Zeta potential measurements: 
The size and zeta potential measurements were performed using a 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) equipped 
with a He-Ne laser (633 nm, fixed scattering angle of 173°) at room 
temperature.
Stability of APT AuNPs (APT ON PEG-AuNPs; APT IN PEG-
AuNPs) as a function of pH
For stability studies, APT AuNPs were dispersed in PBS (0.1 M; pH 
7 and 5.5), and absorption spectra collected over 3 months (Figure S1).
Aptamer loading efficiency: The amount of the AQP2 aptamer 
(APT) incorporated onto APT ON PEG-AuNPs andAPT IN PEG-
AuNPs, were measured by UV-Vis absorption spectroscopy. 
Absorption at 260 nm was used to extrapolate APT concentrations 
based on a calibration curve (Figure S2). The aptamer loading efficiency 
was calculated as follows Equation 1:
( ) 1 2
1
 %  100  C CAPTloading efficiency
C
−
= ×                       (1)
Where C1 is the initial drug content and C2 is the amount of free 
chemistry. Briefly, 50 μl of EDC/NHS (40/10 w/w ratio) aqueous 
solution was added into 2 ml PEG-AuNPs dispersion (42 mM). After 2 
h, 50 µl of aptamer solution (10 µM in PBS pH 9) was added in 2 ml of 
the reaction mixture and stirred for 2 h at room temperature. The APT-
PEG-AuNPs (6APT/NPs) thus obtained were centrifuged two times at 
9,000 rpm for 10 min to remove excess of no-conjugated APT and dried 
under nitrogen.
Aptamer graftings into peg-aunps by complexation 
methodology (apt in peg-aunps)
The second grafting strategy consists of the complexation of the 
AQP2 APT aptamer (50 µl of APT 10 µM; PBS pH 9)(APT) with gold 
salt ( HAuCl4) ( 5 ml 2.6*10-4 M), and 50 µl of PEG-diacide (PEG)( 1 
mM) thought chelation reaction, in order to form APT IN PEG-AuNPs. 
After 18 h the APT IN PEG-AuNPs suspension was centrifuged twice 
at 6000 rpm for 10 min to remove excess of aptamer and then the 
pellets were redispersed in 1 mL MilliQ water. The resultant colloidal 
solution was sonicated for 5 minutes and then stirred for 1 h at room 
temperature.
Physico-chemical characterization 
All the measurements were performed in triplicate in order to 
validate the reproducibility of the synthetic and analytical procedures.
UV/Vis measurements: Absorption spectra were recorded using a 
Perkin Elmer Lambda UV/Vis 950 spectrophotometer in plastic cuvettes 
with an optical path of 10 mm. The wavelength range was 200–900 nm.
Transmission electron microscopy (TEM): TEM images were 
acquired with a JEOL JEM 1011 microscope (JEOL, USA) at an 
accelerating voltage of 100 kV. 2 μl of the particle suspension was placed 
Figure S1 : Changes in the UV-Vis absorption spectra of APT AuNPs when incubated in buffer solution at 
pH 7 (A: APT ON PEG-AuNPs; C: APT IN PEG-AuNPs) and pH 5.5 (B: APT ON PEG-AuNPs; D: APT IN 
PEG-AuNPs) up to three months. 
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APT in the filtrate after separation of the nanoparticles by ultrafiltration 
with an Ultrafree MC centrifugal filter units, (30,000 NMWL, Millipore, 
USA).
Aptamer release from AuNPs: APT releases was evaluated at 
physiological temperature (37°C). aptamer-loaded AuNPs ( APT ON 
PEG-AuNPs; APT IN PEG-AuNPs) were dispersed at concentration 
of 1.5 × 1012 particles/ml in 1.5 ml PBS and performed by dialysis as 
previously described [32]. The concentration of aptamer released from 
AuNPs was expressed as a percentage of the total aptamer concentration 
present in the sample Equation 2 and plotted as a function of time.
%   100 
 
ConcentrationofaptamerreleasedAPT released
Initial aptamerconcentration
= ×                             (2)
Endotoxin content in drug-gold nanoparticles
As routine quality control of the materials prior to biological 
testing, the Pierce LAL Cromogenic Endotoxin Quantitation kit 
(Thermoscientific, France) was used to determine the LPS contamination 
in pegylated gold nanoparticles ( PEG-AuNPs) before and after 
conjugation with AQP2 aptamer(APT ON PEG-AuNPs; APT IN PEG-
AuNPs ) as described previously [33]. Results are reported in Table 1 
as average (ntest = 2) ± standard deviation. Endotoxin contamination 
results were kept into account when defining the type of cytotoxic 
endpoint to be examined. 
Results and Discussion
Formation mechanism of APT AuNPs ( APT ON PEG-
AuNPs; APT IN PEG-AuNPs)
Previously, Spadavecchia et al. have synthetized and conjugated 
pegylated gold nanoparticles (PEG-AuNPs) with biomolecules (protein, 
antibody, peptides, aptamer) by several grafting methodologies 
[2,5,7,31]. Chemical-physical evaluations and biological “in vitro” 
studies of biomolecules onto pegylated-gold-nanoparticles have 
successfully showed a large influence in its therapeutic activity [32-35]. 
Recently, new nano-therapeutic agents based on drugs-gold-
complex such as doxorubicin, docetaxel, paclitaxel, gemcitabine has 
been generated [32,36,37]. According to this experimental approach 
called “Method IN”, the drug interacts actively with gold salt (HAuCl4) 
by chelation bonding and a biocompatible polymer molecules (PEG 
diacid) as surfactant, in order to form hybrid gold nanoparticles under 
reduction with NaBH4. 
Other authors conjugated many type of aptamers in order to study 
the interaction with specific biomarkers [38]. Herein we designed and 
characterized the grafting of the AQP2 aptamer (APT) at the surface 
of the PEG-AuNPs for carbodiimide chemistry (method ON) and 
chelation bond (method IN). In the first case, APT was grafted on the 
surface of pegylated nanoparticles through the formation of amide 
links between the COOH groups embedding the surface of the PEG-
AuNPs and the NH2 groups of the Aptamer (Scheme 1 panel a previous 
activation of EDC/NHS). In the second case, APT participate to the 
stabilization of AuNPs via complexation and electrostatic interaction 
between its chetone and amino groups with chloride auric ions and 
dicarboxylic pegylated chains. 
In particular, the formation of gold NPs from AuCl4- includes some 
mains steps (Scheme 1b):
(1) Complexation of APT-AuCl4- and generation of gold clusters 
[5].
(2)  Initial reduction of APT metal complex to form Au II; 
 (3) Staking process of polymer molecules by electrostatic adsorption 
onto the PEGylayed gold clusters;
(4)  Final reduction of metal ions to form gold particles stabilized by 
molecules of APT.
In the first step, a mixture of APT molecules was added in HAuCl4 
aqueous solution to induce formation of complexes. Then, the positively 
charged APT in water solution shows strong electrostatic interaction 
with the negatively charged AuCl4- ions leading to formation of a hybrid 
complex APT-AuCl4- (scheme 1b). The addition of PEG-COOH on the 
hybrid complex stabilizes it through electrostatic interaction between 
carbonyl and amino groups, improving the kinetics of reduction by 
complexation of Au ions [39] and controlling the growth process of the 
final nanoparticles (APT IN PEG-AuNPs). The steric arrangement of 
APT INPEG-Au clusters before reduction of HAuCl4 was confirmed 
by UV-Vis absorption spectroscopy, TEM and Raman Spectroscopy, as 
reported in the following sections.
Comparative Aptamer grafting: physicochemical evaluation
The UV-visible spectra of PEG-AuNPs exhibited a surface plasmon 
band at 515 nm (Figure 1, black line). After the APT binding onto the 
PEG-AuNPs (APT ON PEG-AuNPs) via EDC/NHS, the plasmon band 
is red-shifted to 523 nm (Figure 1, red line). Besides, we assume that 
Figure S2: (A) UV-Vis absorption spectra of APT at increasing known concentrations. (B) A calibration 
curve (R2 = 0.9997) was extrapolated from such measurements. The amount of APT molecules contained 
into APT ON PEG-AuNPs, APT ON PEG-AuNPs were estimated based on this curve. 
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the red-shift amplitude depends on both the type of bioconjugation 
method and the APT model. Concerning the chelation method, the red-
shift is bigger (to 543 nm) with a decrease in intensity and a significant 
broadening (Figure 1, green line). The red-shift can be displayed by 
modification of dielectric environment of the nanoparticles thus 
confirming the successful functionalization of the AuNPs surface in 
both cases. In particular, the prominent red shift and the broadening 
observed for APT IN PEG-AuNPs can be due to agglomeration between 
the pegylated gold nanoparticles combined to the formation of classical 
van der Waals inter-aptamer interactions [40], thus the different steric 
conformation of APT during the chelation method. The different red-
shift of the plasmon band suggests that each chemical methodology 
(ON and IN) induce a specific chemical behavior of the APT from 
PEG-AuNPs. This will have considerable repercussions on the steric 
conformation of the APT at the PEG-AuNP surface as well as different 
immobilization kinetic [41,42]. Indeed, the chemical conjugation will 
influence the grafting position of the APT. With the carbodiimide 
(EDC/NHS) grafting, the APT is located directly at the gold surface 
decorated by a PEG layer whereas for the chelation method, the APT 
will be located into the core of gold, surface embedded of the PEG 
layer. This chemical behavior is due to a different adsorption onto gold 
facets of APT, based on their different steric conformation of chemical 
groups during nucleation and growth process of PEG-AuNPs. 
Consequently, the color bright violet-blue of the hybrid nanoparticles 
and the UV-Vis spectra remain unaltered after storage for more than 
three months at room temperature suggesting the formation of stable 
colloids suspension. Such observation is very remarkable since the 
nature of capping layer onto AuNPs plays a key role on the success 
of bioconjugation and comparative kinetic [5]. This behavior was 
confirmed by TEM Images. Figure 1-B panel 1 shows a spherical 
pegylated gold nanoparticles utilized as control with a diameter about 
10± 2 nm as described previously [2,5]. After carbodiimide grafting, 
the resulting APT ON PEG-AuNPs appears as circular agglomerate of 
nanoparticles embedded of a dense layer of polymer (Figure 1-B panel 
2). Considering that the size of single aptamer was about 5 nm [43], 
we suppose that APT assume a preferential location of PEG molecules 
onto the particles, with a specific steric arrangement. Contrarily to 
shape of APT ON PEG-AuNPs,, APT IN PEG-AuNPs displays a snow-
like shape, embedded in a shell of PEG, with a similar diameter around 
50 ± 2 nm (Figure 1-B panel 3. Spadavecchia et al. have realized the 
synthesis of analogous nanostructures using dicarboxylic PEG [32,33] 
and drugs, while characteristic snowflakes nanoparticles were obtained 
Figure 1: (A) Normalized UV-Vis absorption spectrum of APT ON PEG-AuNPs (red line), APT IN PEG-AuNPs( green 
line) and PEG-AuNPs ( black line) APT ( blue line) as control, (B) TEM images of PEG-AuNPs before (panel 1) and 
after conjugation  of APT by carboddiimide chemistry (panel 2) and chelation reaction (panel 3). Scale bars: 50 nm; 
10 nm (low and high magnification). Directional arrows showing the presence of an organic APT-PEG layer of few 
nanometres.
Figure 2: (A-B) Raman spectra of the APT ON PEG-AuNPs (green line) and APT IN PEG-AuNPs (red line) compared 
to free PEG-AuNPs (black line). Experimental conditions: λexc = 785 nm; laser power 20 mW; accumulation time 180 s.
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by incorporating protoporphyrin molecules in the growth solution of 
AuNPs [44].
According to previous studies [5,32,45], when APT was mixed to 
gold salt (AuCl4-)complex, the PEG adapt its chemical conformation 
switching from mushroom to brush mode conformation.
The APT binding is confirmed by DLS and Zeta potential 
measurements (Table 1). The hydrodynamic diameter is increased by 
around 10 nm which means an increase of 5 nm of the radius. This 
distance should correspond to a superior value of the aptamer length 
since the hydrodynamic radius includes the interaction with water 
and could not reflect the exact diameter. Moreover, Zeta potential 
measurements show that PEG-AuNPs and APT PEG-AuNPs were 
colloidally stable at physiological pH (z-potential = -28 ±1 MV, -30 mV 
for APT ON -PEG-AuNPs and -33 ±1 mV for APT IN PEG-AuNPs 
with a PdI equal to 0.3) (Table 1). This stability was improved by the 
presence of PEG coating (Table 2) [2].
The APT AuNPs (APT ON PEG-AuNPs; APT IN PEG-AuNPs) were 
also characterized by TEM and have a spherical shape (Figure 1B) with 
a diameter of 10 nm, for PEG-AuNPs confirmed by the hydrodynamic 
diameter measured by zetasizer (Table 2). The stability of APT AuNPs 
in solution, was monitored by the Localized Surface Plasmon (LSP) 
band at 523 nm (APT ON PEG-AuNPs) and 543 nm (APT IN PEG-
AuNPs). Analysis was carried out at pH 5.5 and electrolytic conditions. 
The synthesized APT AuNPs did shows an almost negligible change 
in the LSP band position over a period of three months (Figure S1). 
Some differences in term of LSP were observed between APT ON PEG-
AuNPs and APT IN PEG-AuNPs, due to different chemical behavior of 
APT AuNPs in function of size and shape respectively.
The successful immobilization of AQP2 aptamer onto and/or into 
PEG-AuNPs surface was also demonstrated by Raman spectroscopy 
(Figure 2 A-B). Moreover, we have access to some information 
regarding the aptamer structure with the Raman bands. Raman spectra 
of free gold nanoparticles (PEG-AuNPs) exhibit few bands assigned to 
the PEG molecules (The wide band observed around 1600 cm-1 on the 
Raman spectra is assigned to the water). The detection of the finger 
print of PEG-COOH at the AuNPs surface was demonstrated through 
the observation of the Raman bands at 1137 cm-1, 1270 cm-1, and 1455 
cm-1 due to the vibration of C-O-H, C-O-C and C-O chemical groups, 
respectively (Figure 2, black line). After the aptamer binding, many new 
bands can be observed for both grafting methods used (Figure 2 red line 
(APT ON PEG-AuNPs); Figure 2 green line (APT IN PEG-AuNPs) ). 
More details on the band assignment of APT are showed in the Table 
S1 [46-48]. Several bands are common to the grafted AuNPs but with 
different relative intensities: one peak at 838 cm-1 which corresponds to 
the vibration of the sugar, one at 1536 cm-1 which corresponds to the 
Adenine base and one at 1731 cm-1 which corresponds to ketones in 
the different bases of the aptamer [46]. Some bands are specific to the 
APT as the peak at 1058 cm-1 typical of phosphate group (PO43-) [46] or 
the intense peak at 1371 cm-1 which corresponds to thymine base. Its 
high intensity is due to the good alignment of the aptamer with the Au 
surface of nanoparticles [49], in contrast to the lower signal recorded 
for the case of the free thymine DNA in water [50]. 
If we compare the Raman results of bioconjugation of APT with 
PEG-AuNPs (APT ON PEG-AuNPs; APT IN PEG-AuNPs) it confirms 
that the chemical and steric modification of the aptamer depending of 
the grafting method impacting the conformation of the aptamer. In 
particular the peak at 1528 cm-1 corresponding to Adenine and NH 
out plane, is more pronounced in APT IN PEG-AuNPs compared to 
APT ON PEG-AuNPs, confirming a different sterical disposition of 
APT onto PEG-AuNPs. An effect SRS was observed in the range 300-
300 cm1 correspponding to vibration Au-O-C, Au-Cl, O-O and 2500 
-3500 cm-1 due to C-C aliphatic stretching (Figure 2 panel B). However, 
for each grafting method, we can assume that the aptamer different 
packing density and as a consequence its conformation will be largely 
influence by such parameters.
Aptamer loading and release of APT ONPEG-AuNPs and 
APT IN PEG-AuNPs
Aptamer technology was considered a novel promise in 
therapeutics for its targeting abilities [51]. However, its potential to 
improve drug loading and release from nano carriers has not been 
thoroughly analyzed. Recently Lee JB et al. have proposed a general 
approach for loading a large amount of thrombin proteins using DNA 
aptamer particles [52]; other authors, have developed a new strategy 
of drug-loading by designing drug specific aptamers to drive drugs 
into liposomes [53]. Of note, Dam et al. [54] showed thatloading of 
G-quadruplex DNA aptamer AS1411 onto AuNPs could be tuned by 
manipulating the charge of the ligands and the particle surface by pH. 
They found that as the pH of the solution decreased, repulsion between 
negatively charged nucleic acids and the AuNPs surface decreased, 
which facilitated the covalent attachment of oligonucleotides on Au 
surface. The optimal pH-tunable loading of a therapeutic G-quadruplex 
ligand under acidic medium, was applied on citrate-capped, colloidal 
AuNPs suggesting that this method can be general to a wide range 
of NPs. Based on these encouraging results, we have studied, for the 
first time, the synergic effect of a putative renal aptamer loading onto 
(method ON) and or /into (method IN) pegylated gold nanoparticles 
(PEG-AuNPs) under specific conditions and chemical conjugations.
Table S1: Raman band assignment for the APT and vibrational modes in the 
range spectral 800-1800 cm-1.
Sample Endotoxin Units (EU/ml)
PEG-AuNPs ( control) ND
APT ON PEG-AuNPs >1
APT IN PEG-AuNPs ND
APT >1
Table 1: Endotoxin units detected by means of the LAL Chromogenic Endotoxin 
Quantitation kit (ND = not detectable; >1= above detection limit of the assay).
Synthetic product Zeta potential(mV)
Hydrodynamic 
diameter (nm) PdI
 PEG-AuNPs -28 ± 1 10 ± 2 0.3
 APT ON PEG-AuNPs
 APT IN-PEG-AuNPs
-30 ± 1
-33 ± 1
10 ± 3
50± 2
0.3
0.3
Table 2: z-potential and hydrodynamic diameter of PEG-AuNPs, APT on PEG-
AuNPs and APT IN PEG-AuNPs by carbodiimide and chelation chemistry. 
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In this study, after complexation of AuCl4- with PEG diacid chains, 
APT was covalently bound onto complex after reduction of NaBH4 to 
obtain APT ON PEG-AuNPs. In this novel formulation APT assume 
a different chemical and sterical conformation compared to recent 
synthesis approach in which APT molecules reside inside the AuNP 
core ( APT IN PEG-AuNPs) [32,55]. The successful loading ratio of 
APT onto PEG-AuNPs, were evidenced by the characteristic absorption 
peaks at 260 nm from APT (Figure S2). The standard absorption of 
APT was plotted in the inset of figure (Figure S2) according to UV-
Vis absorbance spectra of APT at various concentrations. The loading 
efficiencies were estimated to be 85% with 8.2 µg present in 2.5 × 10-8 mol 
of NPs (data not shown). A sustained APT release was observed in the 
first 5 h for both nanoparticles (APT ON PEG-AuNPs; APT IN PEG-
AuNPs) at pH 4, which is highly favorable for delivery in the cancer 
cells [56]. We observed that the delivery of APT was favorite when 
the nano-formulation was obtained by method ON (APT ON PEG-
AuNps). Therefore, we supposed, that the release of APT was checked 
by a ionic equilibrium between Au (III)-complexes trapped into AuNPs 
by the hydrophobic interactions between PEG chaines and APT. As 
previously described, the mechanism by which acidic pH triggers drug 
release is probably associated to the presence of carboxylate groups in 
the chemical structure of PEG molecules [32]. Such groups become 
protonated at acidic pH. This reduces the electrostatic interactions 
occurring between PEG and drugs that stabilize the APT ON PEG-
AuNPs structure (Figure 3).
Figure 3: A) APT  release percentage (%) of APT  ON PEG-AuNPs  and APT IN PEG-AuNPs time in PBS (37°C) at 
pH = 4 B) Schematic diagram of APT release under pH conditions.
Figure 4: Cytotoxicity of APT ON PEG-AuNPs and APT IN PEG-AuNPs in renal cells: A) HEK 293 and B) M-1 cells were either left under basal condition (CTR) or 
exposed to PEG-AuNPs (1 µM), APT ON PEG-AuNPs (1 µM) and APT IN PEG-AuNPs (1 µM) for 6, 12, 24, 48 and 72 hours at 37◦C to evaluate NPs cytotoxicity using 
trypan blue exclusion assay. The cell viability was expressed as percentage of live cells vs total cells and normalized in respect to the CTR for each time point. Data 
were expressed as means ± SEM of three independent experiments. p<0.05 was considered statistically significant.
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We suppose that, the ionic strength and protonation of APT onto 
PEG chains improve the water solubility of the APT molecules, taking 
advantage of the drug release from PEG-AuNPs. Indeed, a remarkable 
moiety of APT electrostatically binding onto dissociated complex is 
released, through PEG chain and diffusionphenomena [32,39]. 
Cytotoxicity of apt on PEG-AuNPs and apt in PEG-AuNPs 
in renal cells 
Finally, the potential cytotoxic effect of these NPs on two different 
renal cell lines was evaluated. Human embryonic kidney and (HEK293) 
and mouse collecting duct (M1) cells [30] were exposed to medium 
containing vehicle alone, nanoparticles (PEG-AuNPs i.e. control), 
and nanoparticles produced with the aptamer either within (APT IN 
PEG-AuNPs) or outside (APT ON PEG-AuNPs) the nanoparticles. 
Whenever the aptamer was present the final concentration was 1 µM, 
which was the higher concentration possible according to the initial 
concentration of the solution containing the NPs. Cell viability was 
monitored for up to 72 hours. We found significant cell death, both for 
HEK293 (Figure 4A) 
M-1 (Figure 4B) cells, after 24 h of exposure to APT ON PEG-
AuNPs. No significant cell death was evident for the other experimental 
conditions tested. The apoptosis inductor Staurosporin (5 µM for 6 h) 
has been used as positive control in each experiment (data not shown).
The evaluation of cells viability under exposure of exogenous NPs 
is extremely important considering that, after NPs administration, 
they may migrate to different body sites through the systemic 
circulation. Indeed, several studied demonstrated NPs distribution and 
bioaccumulation within several organs such as liver, spleen, kidneys, 
brain or heart [57-59]. 
A number of recent studies have shown the impact of NPs 
accumulation in the kidneys. Chen et al. [60] described damage to 
proximal tubular cells in mice exposed to copper NPs while Wang 
et al. [61] Observed signs of glomerulonephritis and pathological 
degeneration in renal proximal convoluted tubules after oral titanium 
dioxide administration. These evidence together with our in vitro 
results highlight the urge for a carful risk assessment regarding all 
bioaccumulation sites within the body.
Here, we showed the ability of APT ON PEG-AuNPs to exert a 
significant albeit modest cytotoxic effect. However, further in vitro 
studies are needed to specifically investigate the mechanisms through 
which APT ON PEG-AuNPs induce cell death after 24 h exposure. 
The dissection of the cellular mechanisms leading to nanoparticles-
induced cell death might help the design of nano-molecules and nano-
complexes whose physicochemical characteristic shape, size, chemical 
or physical interactions do not interfere with cellular health. This 
will pave the way for a safer use of these new hybrid nanoparticles in 
biomedical approaches such as drugs delivery and gene therapy. Under 
this scenario, nanoparticles whose size allows renal filtration might 
represent a fascinating strategy to specifically target different parts of 
the nephron segment. In this study, we designed a putative aptamer 
against AQP2, which is a water channel responsible of facultative renal 
water reabsorption. Further investigations are further needed to exploit 
AQP2- nanoparticles based gene therapy to specifically rescue AQP2 
physiological functions in a genetic disease whose main hallmark is 
impaired water reabsorption [62-66]. 
Conclusion
The success of this study was to provide the design, the synthesis 
and the characterization of new hybrid nanoparticles based on the 
incorporation of AQP2 aptamer (APT) PEGylated in gold nanoparticles 
under two chemical methodologies. Chemical physics characterizations 
were extensively achieved and fully elucidated the formation 
mechanism of the nanostructure and the APT conformational changes 
associated with such processes. Aptamer-conjugated PEG-AuNPs 
were assessed for in vitro study on two different renal cell lines, human 
embryonic kidney (HEK293) and mouse collecting duct cells (M-1), 
respectively. Based on different shape and size of different aptamer 
based gold nanoparticles, we will provide in the further, a selective 
study on several renal cells and therapeutic application thought 
phototermal (PTT) studies.
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